Thyroid medication recalled nationwide after tablets found to be 'superpotent': FDA

Live updates

1. 15d ago

   Vitruvias Therapeutics Recalls 30 mg Thyroid Tablets for Over-Potency

   The FDA issued a nationwide recall for Vitruvias Therapeutics 30 mg thyroid tablets after lab tests revealed the medication is superpotent. More than 3,600 bottles are affected. The excessive potency poses a risk of triggering hyperthyroidism, with heightened safety concerns for elderly patients and those who are pregnant. Users must check their product and follow safety protocols to prevent side effects linked to overmedication.

   Why it matters

   Thyroid medications regulate metabolism and heart rate. Over-potency can lead to toxic levels of thyroid hormone in the bloodstream. This recall targets a specific 30 mg dosage across the United States.

   What is confirmed

   • Vitruvias Therapeutics is recalling 30 mg thyroid tablets due to excessive potency.
   • Lab testing showed the pills could be too strong.
   • More than 3,600 bottles of the medication are being recalled nationwide.
   • The potency risk could trigger hyperthyroidism.

   What to watch next

   • FDA announcement of the specific lot numbers affected
   • Reports of adverse patient reactions linked to the superpotent tablets
   Sources used for this update (4)

   1. www.foxbusiness.com — Product Recalls
   2. medicalxpress.com — Thyroid tablets recalled nationwide due to potential over-potency risk
   3. www.dermatologyadvisor.com — Thyroid Tablets Recalled Nationwide Due To Potential Over-Potency Risk
   4. www.nbcchicago.com — Popular cold remedy sold nationwide recalled due to potential contamination
   confidence 90%
2. 20d ago

   FDA Issues Nationwide Recall for Superpotent Thyroid Tablets

   The FDA issued an urgent nationwide recall for thyroid medication after tablets were found to be "superpotent." Vitruvias Therapeutics is recalling 30 mg thyroid tablets because the excessive potency could trigger hyperthyroidism. The recall specifically highlights increased safety risks for pregnant patients and the elderly. Affected users are advised to check their product and follow safety steps to avoid side effects associated with overmedication.

   Why it matters

   Thyroid medication regulates metabolism and hormone levels in the body. Superpotent doses can cause the thyroid to become overactive, leading to hyperthyroidism. This condition can cause heart palpitations, anxiety, and other systemic health issues.

   What is confirmed

   • The FDA issued a nationwide recall for thyroid medication found to be "superpotent."
   • The superpotent tablets could lead to hyperthyroidism.

   Still unconfirmed

   • Vitruvias Therapeutics is recalling 30 mg thyroid tablets specifically risking elderly and pregnant patients.
   • The recall was triggered by fears that superpotency would cause other side effects.

   What to watch next

   • FDA release of specific lot numbers and expiration dates for the recalled tablets.
   • Reports of adverse patient reactions linked to the superpotent medication.
   • Company statement from Vitruvias Therapeutics regarding the cause of the potency error.
   Sources used for this update (8)

   1. Fox Business — Thyroid medication recalled nationwide after tablets found to be 'superpotent': FDA
   2. NBC 5 Chicago — Thyroid tablets recalled because they could be ‘superpotent,' lead to hyperthyroidism
   3. USA Today — Thyroid medicine recalled. See affected product
   4. FOX 8 News — Thyroid tablets could be ‘superpotent,’ warns FDA in urgent recall alert
   5. WTHR — Thyroid medication recalled as product can be 'superpotent,' FDA says
   6. www.foxbusiness.com — Lifestyle and Budget
   7. www.ibtimes.co.uk — Vitruvias Therapeutics Thyroid Tablet Recall: 'Superpotent' Pills Risk Elderly and Pregnant Patients
   8. www.ktvu.com — Thyroid tablets recalled because they may be ‘superpotent’
   confidence 90%